Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Macrogenics
(NASDAQ:MGNX)
Intraday
$14.37
-1.33
[-8.47%]
After-Hours
$14.37
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$14.37
-1.33
[-8.47%]
At close: Apr 25
$14.37
0
[0.00%]
After Hours: 4:00PM EDT
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Macrogenics Stock (NASDAQ:MGNX)
Macrogenics Stock (NASDAQ: MGNX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, April 09, 2024
Macrogenics shares are trading higher after TD Cowen upgraded the stock from Hold to Buy.
Benzinga Newsdesk
-
Apr 9, 2024, 8:28AM
TD Cowen Upgrades Macrogenics to Buy
Benzinga Newsdesk
-
Apr 9, 2024, 6:37AM
Friday, April 05, 2024
Look Out For These 6 Stocks As Analysts Predicts Major Gains, One Up To 82%
Benzinga Neuro
-
Apr 5, 2024, 2:15AM
Thursday, April 04, 2024
MacroGenics Analyst Impressed By Improved Safety Profile From Prostate Cancer Candidate
Vandana Singh
-
Apr 4, 2024, 2:15PM
Why STAAR Surgical Shares Are Trading Higher By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor
-
Apr 4, 2024, 1:21PM
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
-
Apr 4, 2024, 12:31PM
The Latest Analyst Ratings For Macrogenics
Benzinga Insights
-
Apr 4, 2024, 12:01PM
JMP Securities Reiterates Market Outperform on Macrogenics
Benzinga Newsdesk
-
Apr 4, 2024, 8:56AM
MacroGenics shares are trading higher. The stock initially fell after the company provided an update and early interim safety data on its Phase 2 TAMARACK study and has since reversed.
Benzinga Newsdesk
-
Apr 4, 2024, 7:44AM
Simulations Plus Posts Upbeat, Joins Levi Strauss, BlackBerry And Other Big Stocks Moving Higher In Thursday's Pre-Market Session
Avi Kapoor
-
Apr 4, 2024, 5:18AM
Wednesday, April 03, 2024
MacroGenics shares are trading lower after the company announced TAMARACK study data will not be presented at the ASCO Annual Meeting.
Benzinga Newsdesk
-
Apr 3, 2024, 4:40PM
MacroGenics Says TAMARACK Study Data Will Not Be Presented At ASCO Annual Meeting But Co. Intends To Maintain Previously Disclosed Plan To Share Further TAMARACK Interim Data By End Of May
Benzinga Newsdesk
-
Apr 3, 2024, 4:33PM
Monday, March 11, 2024
Citigroup Maintains Buy on Macrogenics, Raises Price Target to $25
Benzinga Newsdesk
-
Mar 11, 2024, 11:59AM
JMP Securities Maintains Outperform on Macrogenics, Raises Price Target to $22
Benzinga Newsdesk
-
Mar 11, 2024, 7:23AM
HC Wainwright & Co. Maintains Neutral on Macrogenics, Raises Price Target to $16
Benzinga Newsdesk
-
Mar 11, 2024, 6:43AM
Friday, March 08, 2024
BMO Capital Maintains Outperform on Macrogenics, Raises Price Target to $24
Benzinga Newsdesk
-
Mar 8, 2024, 11:22AM
Stifel Maintains Buy on Macrogenics, Raises Price Target to $29
Benzinga Newsdesk
-
Mar 8, 2024, 10:42AM
MacroGenics shares are trading lower after the company reported Q4 Results.
Benzinga Newsdesk
-
Mar 8, 2024, 7:04AM
Barclays Maintains Overweight on Macrogenics, Raises Price Target to $25
Benzinga Newsdesk
-
Mar 8, 2024, 6:06AM
Thursday, March 07, 2024
MacroGenics shares are trading lower after the company reported a year-over-year decrease in Q4 revenue results.
Benzinga Newsdesk
-
Mar 7, 2024, 5:04PM
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
-
Mar 7, 2024, 4:31PM
Macrogenics: Q4 Earnings Insights
Benzinga Insights
-
Mar 7, 2024, 4:15PM
Macrogenics Q4 2023 GAAP EPS $(0.750), Sales $10.720M Down From $73.099M YoY
Benzinga Newsdesk
-
Mar 7, 2024, 4:14PM
Earnings Scheduled For March 7, 2024
Benzinga Insights
-
Mar 7, 2024, 4:49AM
Wednesday, March 06, 2024
A Preview Of Macrogenics's Earnings
Benzinga Insights
-
Mar 6, 2024, 11:01AM
Monday, March 04, 2024
Analyst Expectations For Macrogenics's Future
Benzinga Insights
-
Mar 4, 2024, 3:01PM
AMD To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Monday
Avi Kapoor
-
Mar 4, 2024, 7:56AM
BTIG Maintains Buy on Macrogenics, Raises Price Target to $24
Benzinga Newsdesk
-
Mar 4, 2024, 7:05AM
Thursday, February 29, 2024
Barclays Maintains Overweight on Macrogenics, Raises Price Target to $23
Benzinga Newsdesk
-
Feb 29, 2024, 8:36AM
Monday, February 26, 2024
Surgery Partners Posts Weak Sales, Joins Kosmos Energy, Moderna And Other Big Stocks Moving Lower On Monday
Avi Kapoor
-
Feb 26, 2024, 11:18AM
Wednesday, February 14, 2024
Decoding 4 Analyst Evaluations For Macrogenics
Benzinga Insights
-
Feb 14, 2024, 7:00AM
HC Wainwright & Co. Downgrades Macrogenics to Neutral, Raises Price Target to $14
Benzinga Newsdesk
-
Feb 14, 2024, 6:30AM
Wednesday, January 24, 2024
Demystifying Macrogenics: Insights From 5 Analyst Reviews
Benzinga Insights
-
Jan 24, 2024, 1:00PM
JMP Securities Maintains Market Outperform on Macrogenics, Raises Price Target to $16
Benzinga Newsdesk
-
Jan 24, 2024, 12:18PM
Friday, January 19, 2024
World Acceptance Posts Upbeat Earnings, Joins Kaman, Spirit Airlines And Other Big Stocks Moving Higher On Friday
Avi Kapoor
-
Jan 19, 2024, 10:20AM
Wednesday, December 20, 2023
Why Steelcase Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
-
Dec 20, 2023, 1:16PM
MacroGenics shares are trading higher after Citigroup upgraded the stock from Neutral to Buy and raised its price target from $7 to $13.
Benzinga Newsdesk
-
Dec 20, 2023, 10:51AM
Toro Posts Upbeat Results, Joins Clear Channel Outdoor, Marathon Digital And Other Big Stocks Moving Higher On Wednesday
Avi Kapoor
-
Dec 20, 2023, 10:10AM
Top 4 Health Care Stocks That May Crash This Month
Avi Kapoor
-
Dec 20, 2023, 8:31AM
EnerSys To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Wednesday
Avi Kapoor
-
Dec 20, 2023, 7:50AM
Forecasting The Future: 4 Analyst Projections For Macrogenics
Benzinga Insights
-
Dec 20, 2023, 7:00AM
Citigroup Upgrades Macrogenics to Buy, Raises Price Target to $13
Benzinga Newsdesk
-
Dec 20, 2023, 4:20AM
Monday, November 27, 2023
Stifel Reiterates Buy on Macrogenics, Maintains $17 Price Target
Benzinga Newsdesk
-
Nov 27, 2023, 1:36PM
Monday, November 13, 2023
HC Wainwright & Co. Maintains Buy on Macrogenics, Lowers Price Target to $12
Benzinga Newsdesk
-
Nov 13, 2023, 11:21AM
Tuesday, November 07, 2023
Why Sanmina Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin
-
Nov 7, 2023, 1:10PM
MacroGenics shares are trading higher after the company reported Q3 financial results. Following earnings, Guggenheim upgraded the stock from Neutral to Buy and announced a $12 price target.
Benzinga Newsdesk
-
Nov 7, 2023, 12:29PM
Datadog, Tripadvisor, Myriad Genetics, Planet Fitness And Other Big Stocks Moving Higher On Tuesday
Lisa Levin
-
Nov 7, 2023, 10:54AM
Guggenheim Upgrades Macrogenics to Buy, Announces $12 Price Target
Benzinga Newsdesk
-
Nov 7, 2023, 7:38AM
Monday, November 06, 2023
Macrogenics Q3 EPS $0.28 Beats $(0.10) Estimate, Sales $10.40M Miss $48.86M Estimate
Benzinga Newsdesk
-
Nov 6, 2023, 4:28PM
Earnings Scheduled For November 6, 2023
Benzinga Insights
-
Nov 6, 2023, 8:24AM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch